When 80% of oncology patients face nutrition-related health risks, you'd expect clinical nutrition to be front-page news. Instead, this massive healthcare segment quietly powers recovery in hospitals, long-term care facilities, and homes worldwide while most people focus on flashier medical technologies.
The clinical nutrition market tells a sobering story about our aging world. With cancer cases in Europe alone jumping from 2.74 million in 2022 to an expected 3.24 million by 2040, specialized nutritional interventions aren't luxury add-ons anymore-they're medical necessities. Factor in rising preterm birth rates in wealthier countries and growing chronic disease prevalence, and you have a market expanding from $75.5 billion in 2025 to $104.7 billion by 2031, growing at 5.6% annually.
North America dominates with 47.1% market share, but the real innovation is happening in unexpected places. Companies like Nestlé, Abbott, and Fresenius Kabi are pouring R&D dollars into AI-driven precision nutrition and Food-as-Medicine solutions. Blenderized tube feeding using whole foods is replacing traditional formulas, while telehealth platforms enable remote nutritional screening using digital diagnostic units with laser sensors.
The challenges are equally compelling. Geopolitical tensions disrupt supply chains, insurance reimbursement varies wildly across regions, and complex regulatory frameworks slow product launches. Yet major players from Danone to Otsuka Holdings continue investing heavily.
Want the full picture? Download the free overview of our report Clinical Nutrition: Global Markets to 2031 for detailed market forecasts, technology trends, and competitive analysis.
